UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

Anti-TNF therapy: past, present and future

International immunology, 2015-01, Vol.27 (1), p.55-62

2015

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in the understanding of Dupuytren's disease [version 1; peer review: 3 approved]

F1000 research, 2019, Vol.8, p.231

2019

Link zum Volltext

Verfügbarkeit prüfen

TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells

Proceedings of the National Academy of Sciences - PNAS, 2011-01, Vol.108 (4), p.1585-1590

2011

Link zum Volltext

Verfügbarkeit prüfen

Cellular census of human fibrosis defines functionally distinct stromal cell types and states

Nature communications, 2020-06, Vol.11 (1), p.2768-2768, Article 2768

2020

Link zum Volltext

Verfügbarkeit prüfen

Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert

Proceedings of the National Academy of Sciences - PNAS, 2018-05, Vol.115 (19), p.E4463-E4472

2018

Link zum Volltext

Verfügbarkeit prüfen

Anti-TNF Therapy

Microbiology spectrum, 2016-08, Vol.4 (4)

2016

Link zum Volltext

Verfügbarkeit prüfen

A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis

American journal of human genetics, 2017-09, Vol.101 (3), p.417-427

2017

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Cellular census of human fibrosis defines functionally distinct stromal cell types and states

Nature communications, 2020-06, Vol.11 (1), p.3275-3275, Article 3275

2020

Link zum Volltext

Verfügbarkeit prüfen

Does negative pressure wound therapy influence subjacent bacterial growth? A systematic review

Journal of plastic, reconstructive & aesthetic surgery, 2017-08, Vol.70 (8), p.1028-1037

2017

Link zum Volltext

Verfügbarkeit prüfen

Autofluorescence Lifetime Reports Cartilage Damage in Osteoarthritis

Scientific reports, 2020-02, Vol.10 (1), p.2154-2154, Article 2154

2020

Link zum Volltext

Verfügbarkeit prüfen

A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren's disease

Nature communications, 2024-01, Vol.15 (1), p.199-199, Article 199

2024

Link zum Volltext

Verfügbarkeit prüfen

Low‐dose TNF augments fracture healing in normal and osteoporotic bone by up‐regulating the innate immune response

EMBO molecular medicine, 2015-05, Vol.7 (5), p.547-561

2015

Link zum Volltext

Verfügbarkeit prüfen

Anti-TNF (adalimumab) injection for the treatment of pain-predominant early-stage frozen shoulder: the Anti-Freaze-Feasibility randomised controlled trial

BMJ open, 2024-05, Vol.14 (5), p.e078273-e078273

2024

Link zum Volltext

Verfügbarkeit prüfen

Negative-pressure wound therapy compared with standard dressings following surgical treatment of major trauma to the lower limb: the WHiST RCT

Health technology assessment (Winchester, England), 2020-08, Vol.24 (38), p.1-86

2020

Link zum Volltext

Verfügbarkeit prüfen

What do we know about managing Dupuytren's disease cost-effectively?

BMC musculoskeletal disorders, 2018-01, Vol.19 (1), p.34-34, Article 34

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of adalimumab for early-stage Dupuytren's disease : an economic evaluation based on a randomized controlled trial and individual-patient simulation model

Bone & joint open, 2022-11, Vol.3 (11), p.898-906

2022

Link zum Volltext

Verfügbarkeit prüfen

Strategies to overcome the hurdles to treat fibrosis, a major unmet clinical need

Proceedings of the National Academy of Sciences - PNAS, 2016-07, Vol.113 (27), p.7291-7293

2016

Link zum Volltext

Verfügbarkeit prüfen

Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial

NIHR open research, 2022-04, Vol.2, p.28

2022

Link zum Volltext

Verfügbarkeit prüfen

Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial

EBioMedicine, 2018-07, Vol.33, p.282-288

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis

Science advances, 2019-12, Vol.5 (12), p.eaay0370-eaay0370

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial

NIHR open research, 2022-01, Vol.2, p.28-28

2022

Link zum Volltext

Verfügbarkeit prüfen

Myofibroblast Distribution in Dupuytren's Cords: Correlation With Digital Contracture

The Journal of hand surgery (American ed.), 2009-12, Vol.34 (10), p.1785-1794

2009

Link zum Volltext

Verfügbarkeit prüfen

Collagen VI as a driver and disease biomarker in human fibrosis

The FEBS journal, 2022-07, Vol.289 (13), p.3603-3629

2022

Link zum Volltext

Verfügbarkeit prüfen

Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states

Biology open, 2020, Vol.9 (3)

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(124)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(69)
Humans
(68)
Surgery
(50)
Biological And Medical Sciences
(24)
Male
(24)
Medical Sciences
(24)
Animals
(20)
Female
(20)
Orthopedics
(20)
Middle Aged
(19)
Adult
(17)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(14)
Aged
(13)
Rheumatology
(13)
Fractures, Open - Surgery
(12)
Treatment Outcome
(12)
Fibrosis
(11)
Aged, 80 And Over
(10)
Cells, Cultured
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Anti-TNF therapy: past, present and future

Recent advances in the understanding of Dupuytren's disease [version 1; peer review: 3 approved]

TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells

Cellular census of human fibrosis defines functionally distinct stromal cell types and states

Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert

Anti-TNF Therapy

A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis

Author Correction: Cellular census of human fibrosis defines functionally distinct stromal cell types and states

Does negative pressure wound therapy influence subjacent bacterial growth? A systematic review

Autofluorescence Lifetime Reports Cartilage Damage in Osteoarthritis

A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren's disease

Low‐dose TNF augments fracture healing in normal and osteoporotic bone by up‐regulating the innate immune response

Anti-TNF (adalimumab) injection for the treatment of pain-predominant early-stage frozen shoulder: the Anti-Freaze-Feasibility randomised controlled trial

Negative-pressure wound therapy compared with standard dressings following surgical treatment of major trauma to the lower limb: the WHiST RCT

What do we know about managing Dupuytren's disease cost-effectively?

PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) – a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study

Cost-effectiveness of adalimumab for early-stage Dupuytren's disease : an economic evaluation based on a randomized controlled trial and individual-patient simulation model

Strategies to overcome the hurdles to treat fibrosis, a major unmet clinical need

Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial

Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial

Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis

Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial

Myofibroblast Distribution in Dupuytren's Cords: Correlation With Digital Contracture

Collagen VI as a driver and disease biomarker in human fibrosis

Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states

Suchergebnisse filtern